Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Newbold

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|January 18, 2011
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialChristopher M Nutting, James P Morden, Kevin J Harrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2012
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignanciesEleni M Karapanagiotou, Victoria Roulstone, Katie Twigger, et al.
Cancer|April 28, 2015
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessmentMaria E Cabanillas, Martin Schlumberger, Barbara Jarzab, et al.
Thyroid : Official Journal of the American Thyroid Association|March 17, 2021
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid CancerKeith C Bible, Electron Kebebew, James Brierley, et al.
Cancers|April 3, 2021
Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort StudyIfigenia Vasiliadou, Omar Breik, Holly Baker, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 24, 2025
Anaplastic Thyroid Carcinoma: A Contemporary Review of Challenges and AdvancesAmanda Silver Karcioglu, Cristian Slough, Symone V Jordan, et al.
Thyroid : Official Journal of the American Thyroid Association|November 29, 2018
European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International SymposiumMarkus Luster, Cumali Aktolun, Isabel Amendoeira, et al.
The New England Journal of Medicine|February 12, 2015
Lenvatinib versus placebo in radioiodine-refractory thyroid cancerMartin Schlumberger, Makoto Tahara, Lori J Wirth, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 11, 2024
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 UpdateLindsay A Bischoff, Ian Ganly, Laura Fugazzola, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|January 18, 2011
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialChristopher M Nutting, James P Morden, Kevin J Harrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2012
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignanciesEleni M Karapanagiotou, Victoria Roulstone, Katie Twigger, et al.
Cancer|April 28, 2015
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessmentMaria E Cabanillas, Martin Schlumberger, Barbara Jarzab, et al.
Thyroid : Official Journal of the American Thyroid Association|March 17, 2021
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid CancerKeith C Bible, Electron Kebebew, James Brierley, et al.
Cancers|April 3, 2021
Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort StudyIfigenia Vasiliadou, Omar Breik, Holly Baker, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 24, 2025
Anaplastic Thyroid Carcinoma: A Contemporary Review of Challenges and AdvancesAmanda Silver Karcioglu, Cristian Slough, Symone V Jordan, et al.
Thyroid : Official Journal of the American Thyroid Association|November 29, 2018
European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International SymposiumMarkus Luster, Cumali Aktolun, Isabel Amendoeira, et al.
The New England Journal of Medicine|February 12, 2015
Lenvatinib versus placebo in radioiodine-refractory thyroid cancerMartin Schlumberger, Makoto Tahara, Lori J Wirth, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 11, 2024
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 UpdateLindsay A Bischoff, Ian Ganly, Laura Fugazzola, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
Pageof 8